SCHEMBL1040404

SCHEMBL1040404

CC(=O)OCC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1042350 0.90 TRPV1 (0.82) TRPV1
SCHEMBL1039230 0.89 TRPV1 (0.81) TRPV1
Amg-517 SCHEMBL1042780 0.89 TRPV1 (1.00) TRPV1
Amg-517 SCHEMBL29360942 0.89 TRPV1 (1.00) TRPV1
Amg-517 SCHEMBL29389509 0.89 TRPV1 (1.00) TRPV1
SCHEMBL1040601 0.89 TRPV1 (0.80) TRPV1
SCHEMBL4255931 0.88 TRPV1 (0.69) TRPV1
SCHEMBL5968285 0.88 TRPV1 (0.79) TRPV1
SCHEMBL1042449 0.87 TRPV1 (0.85) TRPV1
SCHEMBL3976566 0.87 TRPV1 (0.67) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2270006-A1 Pyridazine derivatives useful as vanilloid receptor ligands Amgen, Inc (US) 2011-01-05 EP disclosed
US-7332511-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-02-19 US disclosed
US-7332511-B2 Vanilloid receptor ligands and their use in treatments AMGEN INC. (US) 2008-02-19 US disclosed